Overview

Liraglutide for HIV-associated Neurocognitive Disorder

Status:
Suspended
Trial end date:
2020-05-01
Target enrollment:
Participant gender:
Summary
This study will test the effect of liraglutide on cognitive function in HIV-infected overweight or obese subjects with type 2 diabetes.
Phase:
Phase 4
Details
Lead Sponsor:
Temple University
Collaborator:
The Comprehensive NeuroAIDS Center (CNAC) at Temple University
Treatments:
Liraglutide